This protocol describes the Lifebox trial evaluating Clean Cut's ability to reduce infections following cesarean sections in Ethiopia
Cesarean section (C-section) is the most commonly performed major operation in the world. Patients undergoing C-sections are at risk of surgical site infection (SSI) – a common and devastating complication of surgery. Infection rates are particularly high in low- and middle-income countries (LMICs).
Lifebox is working with partners to adapt its surgical infection reduction program – Clean Cut – to improve the safety of C-sections in Ethiopia where the majority of C-sections are essential surgical procedures. In Ethiopia, there is an estimated SSI rate following C-section of 9% and infections and complications following C-sections are estimated to cause 15% of maternal deaths in the country.
We are currently implementing the program at nine maternity hospitals in Ethiopia as part of a rigorous study to evaluate its impact in C-section care, and improve the safety of women undergoing this common operation. So far, 7,000 patients have been observed as part of the study.